APA (7th ed.) Citation

Nowak, R. J., Habib, A. A., Klink, A. J., Muppidi, S., Parthan, A., Sader, S. C., . . . Howard, J. F. (2024). US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization. Drugs - Real World Outcomes, 11(4), 593-601. https://doi.org/10.1007/s40801-024-00457-8

Chicago Style (17th ed.) Citation

Nowak, Richard J., Ali A. Habib, Andrew J. Klink, Srikanth Muppidi, Anju Parthan, S. Chloe Sader, Alexandrina Balanean, Ajeet Gajra, and James F. Howard. "US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization." Drugs - Real World Outcomes 11, no. 4 (2024): 593-601. https://doi.org/10.1007/s40801-024-00457-8.

MLA (9th ed.) Citation

Nowak, Richard J., et al. "US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization." Drugs - Real World Outcomes, vol. 11, no. 4, 2024, pp. 593-601, https://doi.org/10.1007/s40801-024-00457-8.